This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 May 23;385(9982):2020-2.

doi: 10.1016/S0140-6736(15)60615-8.

An alternative combination therapy for type 2 diabetes?

Signe H Østoft¹, Mikkel Christensen²

Affiliations

Affiliations

¹ Center for Diabetes Research, Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup 2900, Denmark. Electronic address: s.ostoft@dadlnet.dk.
² Center for Diabetes Research, Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup 2900, Denmark; Department of Clinical Pharmacology, Bispebjerg Hospital, University of Copenhagen, Hellerup 2900, Denmark.

PMID: 26009215
DOI: 10.1016/S0140-6736(15)60615-8

Comment

An alternative combination therapy for type 2 diabetes?

Signe H Østoft et al. Lancet. 2015.

. 2015 May 23;385(9982):2020-2.

doi: 10.1016/S0140-6736(15)60615-8.

Authors

Signe H Østoft¹, Mikkel Christensen²

Affiliations

¹ Center for Diabetes Research, Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup 2900, Denmark. Electronic address: s.ostoft@dadlnet.dk.
² Center for Diabetes Research, Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup 2900, Denmark; Department of Clinical Pharmacology, Bispebjerg Hospital, University of Copenhagen, Hellerup 2900, Denmark.

PMID: 26009215
DOI: 10.1016/S0140-6736(15)60615-8

No abstract available

PubMed Disclaimer

Comment on

Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study.
Blonde L, Jendle J, Gross J, Woo V, Jiang H, Fahrbach JL, Milicevic Z. Blonde L, et al. Lancet. 2015 May 23;385(9982):2057-66. doi: 10.1016/S0140-6736(15)60936-9. Lancet. 2015. PMID: 26009229 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information